SUMMARY The increasing prevalence of neoplasias is associated with new clinical challenges, one of which is acute kidney injury (AKI). In addition to possibly constituting a clinical emergency, kidney failure significantly interferes with the choice and continuation of antineoplastic therapy, with progno...
Objetivo: analisar as atitudes de enfermeiros acerca da administração de antineoplásicos em oncologia pediátrica. Método: estudo descritivo, com análise estatística dos dados. Participaram 20 enfermeiros de um hospital de ensino, localizado na capital paulista, que administravam quimioterapia (QT)...
Abstract Objective To identify the biomarkers of response to neoadjuvant chemotherapy in early luminal breast cancer. Methods A cross-sectional study that included all patients with early or locallyadvanced luminal breast cancer submitted to neoadjuvant chemotherapy between 2013 and 2014. Demographic...
Antineoplásicos/uso terapéutico,
Neoplasias de la Mama/tratamiento farmacológico,
Neoplasias de la Mama/genética,
Quimioterapia Adyuvante,
Estudios Transversales,
Expresión Génica,
Antígeno Ki-67/genética,
Antígeno Ki-67/metabolismo,
Menopausia,
Persona de Mediana Edad,
Terapia Neoadyuvante,
Receptor ErbB-2/genética,
Receptor ErbB-2/metabolismo,
Receptores de Estrógenos/genética,
Receptores de Estrógenos/metabolismo,
Receptores de Progesterona/genética,
Receptores de Progesterona/metabolismo
El síndrome de lisis tumoral (SLT) es una entidad poco frecuente y potencialmente fatal. Representa una emergencia oncológica. Puede diagnosticarse por su forma de presentación clínica y también por los resultados de laboratorio. En la mayoría de los casos se presenta como complicación del tratami...
ABSTRACT Objective: To construct and validate an educational technology (ET) on fatigue and non-pharmacological strategies for the management of this symptom in people with cancer undergoing outpatient antineoplastic chemotherapy. Method: This is a methodological study composed of three stages: 1) elab...
Antineoplásicos/efectos adversos,
Tecnología Educacional/métodos,
Metabolismo Energético,
Terapia por Ejercicio,
Fatiga/inducido químicamente,
Fatiga/terapia,
Neoplasias/tratamiento farmacológico,
Pacientes Ambulatorios,
Proyectos Piloto,
Reproducibilidad de los Resultados,
Higiene del Sueño
Chemotherapy and radiotherapy are aggressive treatments for cancer management. Both therapies make the stomatogatic system vulnerable to adverse effects on the oral mucosa and hard tissues. This may result in severe oral complications that can affect the quality of life of the oncologic patient. Conseque...
Abstract Primary male genital melanomas are very rare; they are associated with high mortality and late detection. Scrotal melanoma is the least common presentation and only 23 cases have been reported. Herein, the authors present a 30-year-old patient with stage IIIC (T4b, N2a, M0) scrotal melanoma in o...
Antineoplásicos/administración & dosificación,
Biopsia,
Neoplasias de los Genitales Masculinos/tratamiento farmacológico,
Neoplasias de los Genitales Masculinos/patología,
Interferón alfa-2/administración & dosificación,
Melanoma/tratamiento farmacológico,
Melanoma/patología,
Estadificación de Neoplasias,
Escroto/patología,
Neoplasias Cutáneas/tratamiento farmacológico,
Neoplasias Cutáneas/patología
Objective: Chemotherapy treatment against cancer produce systemic toxicities, among which are those related to important structures of the stomatognathic system and its functional activity. 5 Fluorouracil (5-FU) and cyclophosphamide (Cf) are drugs widely used in solid tumors and in bone marrow transplant...
Background The outcome of patients with primary extranodal diffuse large B-cell lymphoma (PE-DLBCL) varies according to the primary site involved. Primary gastrointestinal, breast, bone, craniofacial, and testicular DLBCL are rare extranodal manifestations of DLBCL. Objective The objective of the study ...
Antineoplásicos/administración & dosificación,
Estudios de Cohortes,
Terapia Combinada,
Inmunoterapia/métodos,
Ganglios Linfáticos/patología,
Linfoma de Células B Grandes Difuso/patología,
Linfoma de Células B Grandes Difuso/terapia,
Pronóstico,
Estudios Retrospectivos,
Tasa de Supervivencia,
Resultado del Tratamiento
